GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Idera Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Idera Pharmaceuticals is IDRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Idera Pharmaceuticals Stock?
Idera Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Idera Pharmaceuticals Stock?
Idera Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Idera Pharmaceuticals Stock.

What's the current price of Idera Pharmaceuticals Stock?
As of the end of day on the 2023-04-19, the price of an Idera Pharmaceuticals (IDRA) share was $4.71.

What is the 52-week high and low for Idera Pharmaceuticals Stock?
The 52-week high for Idera Pharmaceuticals Stock is $16.00 and the 52-week low is $0.215.
Click to get the best stock tips daily for free!

About Idera Pharmaceuticals

Idera Pharmaceuticals Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a col... IDRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT